nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—DRD1—attention deficit hyperactivity disorder	0.358	0.444	CbGaD
Acepromazine—DRD2—attention deficit hyperactivity disorder	0.253	0.313	CbGaD
Acepromazine—HTR2A—attention deficit hyperactivity disorder	0.195	0.242	CbGaD
Acepromazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00604	0.15	CbGeAlD
Acepromazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00321	0.0797	CbGeAlD
Acepromazine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00192	0.0476	CbGeAlD
Acepromazine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00152	0.0377	CbGeAlD
Acepromazine—DRD1—midbrain—attention deficit hyperactivity disorder	0.00127	0.0315	CbGeAlD
Acepromazine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00125	0.0312	CbGeAlD
Acepromazine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00116	0.0287	CbGeAlD
Acepromazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.00113	0.0281	CbGeAlD
Acepromazine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.00112	0.0277	CbGeAlD
Acepromazine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.00108	0.0267	CbGeAlD
Acepromazine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.00106	0.0263	CbGeAlD
Acepromazine—DRD1—nervous system—attention deficit hyperactivity disorder	0.00104	0.0259	CbGeAlD
Acepromazine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.001	0.0249	CbGeAlD
Acepromazine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000978	0.0243	CbGeAlD
Acepromazine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000854	0.0212	CbGeAlD
Acepromazine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000828	0.0206	CbGeAlD
Acepromazine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000824	0.0205	CbGeAlD
Acepromazine—DRD1—brain—attention deficit hyperactivity disorder	0.000796	0.0198	CbGeAlD
Acepromazine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000794	0.0197	CbGeAlD
Acepromazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000748	0.0186	CbGeAlD
Acepromazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000747	0.0186	CbGeAlD
Acepromazine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000681	0.0169	CbGeAlD
Acepromazine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000655	0.0163	CbGeAlD
Acepromazine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000641	0.0159	CbGeAlD
Acepromazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000632	0.0157	CbGeAlD
Acepromazine—SLC22A1—brain—attention deficit hyperactivity disorder	0.00063	0.0156	CbGeAlD
Acepromazine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000628	0.0156	CbGeAlD
Acepromazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000615	0.0153	CbGeAlD
Acepromazine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000604	0.015	CbGeAlD
Acepromazine—ALB—brain—attention deficit hyperactivity disorder	0.000603	0.015	CbGeAlD
Acepromazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000592	0.0147	CbGeAlD
Acepromazine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000591	0.0147	CbGeAlD
Acepromazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000579	0.0144	CbGeAlD
Acepromazine—HTR1A—brain—attention deficit hyperactivity disorder	0.00052	0.0129	CbGeAlD
Acepromazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000494	0.0123	CbGeAlD
Acepromazine—ADRA1A—brain—attention deficit hyperactivity disorder	0.00048	0.0119	CbGeAlD
Acepromazine—DRD2—brain—attention deficit hyperactivity disorder	0.00047	0.0117	CbGeAlD
Acepromazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000406	0.0101	CbGeAlD
Acepromazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000391	0.0097	CbGeAlD
Acepromazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000382	0.00948	CbGeAlD
Acepromazine—HTR2A—brain—attention deficit hyperactivity disorder	0.00031	0.0077	CbGeAlD
Acepromazine—Diltiazem—CACNA1C—attention deficit hyperactivity disorder	0.000289	0.0338	CrCbGaD
Acepromazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000263	0.0306	CrCbGaD
Acepromazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000235	0.0275	CrCbGaD
Acepromazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000232	0.0271	CrCbGaD
Acepromazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000222	0.0259	CrCbGaD
Acepromazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000216	0.0252	CrCbGaD
Acepromazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000185	0.0216	CrCbGaD
Acepromazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000179	0.0209	CrCbGaD
Acepromazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000161	0.0188	CrCbGaD
Acepromazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000146	0.017	CrCbGaD
Acepromazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000144	0.0168	CrCbGaD
Acepromazine—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000143	0.0167	CrCbGaD
Acepromazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000143	0.0167	CrCbGaD
Acepromazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000141	0.0164	CrCbGaD
Acepromazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00014	0.0163	CrCbGaD
Acepromazine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	0.000133	0.0155	CrCbGaD
Acepromazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000126	0.0147	CrCbGaD
Acepromazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000126	0.0147	CrCbGaD
Acepromazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.000124	0.0145	CrCbGaD
Acepromazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.00012	0.014	CrCbGaD
Acepromazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.000119	0.0139	CrCbGaD
Acepromazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000115	0.0134	CrCbGaD
Acepromazine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000115	0.0134	CrCbGaD
Acepromazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000114	0.0133	CrCbGaD
Acepromazine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000113	0.0132	CrCbGaD
Acepromazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.000107	0.0125	CrCbGaD
Acepromazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.0123	CrCbGaD
Acepromazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000104	0.0122	CrCbGaD
Acepromazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.000104	0.0121	CrCbGaD
Acepromazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.000103	0.012	CrCbGaD
Acepromazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.000102	0.0119	CrCbGaD
Acepromazine—Thiothixene—DRD2—attention deficit hyperactivity disorder	0.000101	0.0118	CrCbGaD
Acepromazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.000101	0.0118	CrCbGaD
Acepromazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	9.97e-05	0.0116	CrCbGaD
Acepromazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	9.92e-05	0.0116	CrCbGaD
Acepromazine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	9.88e-05	0.0115	CrCbGaD
Acepromazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	9.8e-05	0.0114	CrCbGaD
Acepromazine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	9.69e-05	0.0113	CrCbGaD
Acepromazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	9.66e-05	0.0113	CrCbGaD
Acepromazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	9.47e-05	0.011	CrCbGaD
Acepromazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	9.18e-05	0.0107	CrCbGaD
Acepromazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	9.1e-05	0.0106	CrCbGaD
Acepromazine—Promazine—DRD1—attention deficit hyperactivity disorder	8.83e-05	0.0103	CrCbGaD
Acepromazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	8.73e-05	0.0102	CrCbGaD
Acepromazine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	8.64e-05	0.0101	CrCbGaD
Acepromazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	8.4e-05	0.0098	CrCbGaD
Acepromazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	8.21e-05	0.00957	CrCbGaD
Acepromazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	8.03e-05	0.00937	CrCbGaD
Acepromazine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	7.95e-05	0.00928	CrCbGaD
Acepromazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	7.94e-05	0.00926	CrCbGaD
Acepromazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	7.92e-05	0.00924	CrCbGaD
Acepromazine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	7.81e-05	0.00911	CrCbGaD
Acepromazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	7.81e-05	0.00911	CrCbGaD
Acepromazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	7.77e-05	0.00907	CrCbGaD
Acepromazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	7.71e-05	0.00899	CrCbGaD
Acepromazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	7.53e-05	0.00878	CrCbGaD
Acepromazine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	7.39e-05	0.00862	CrCbGaD
Acepromazine—Trimipramine—DRD2—attention deficit hyperactivity disorder	7.35e-05	0.00857	CrCbGaD
Acepromazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	7.33e-05	0.00855	CrCbGaD
Acepromazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	7.22e-05	0.00842	CrCbGaD
Acepromazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	7.18e-05	0.00838	CrCbGaD
Acepromazine—Promethazine—DRD2—attention deficit hyperactivity disorder	7.08e-05	0.00826	CrCbGaD
Acepromazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	6.98e-05	0.00815	CrCbGaD
Acepromazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	6.91e-05	0.00806	CrCbGaD
Acepromazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	6.75e-05	0.00787	CrCbGaD
Acepromazine—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.66e-05	0.000459	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.66e-05	0.000458	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.61e-05	0.000455	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	6.59e-05	0.000454	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.53e-05	0.000449	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.52e-05	0.000449	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.49e-05	0.000447	CbGpPWpGaD
Acepromazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	6.49e-05	0.00757	CrCbGaD
Acepromazine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	6.46e-05	0.00754	CrCbGaD
Acepromazine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.44e-05	0.000444	CbGpPWpGaD
Acepromazine—Desipramine—DRD2—attention deficit hyperactivity disorder	6.43e-05	0.0075	CrCbGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.41e-05	0.000442	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.41e-05	0.000442	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.34e-05	0.000437	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.34e-05	0.000436	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.31e-05	0.000435	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.29e-05	0.000433	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.27e-05	0.000432	CbGpPWpGaD
Acepromazine—Promazine—DRD2—attention deficit hyperactivity disorder	6.23e-05	0.00726	CrCbGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.22e-05	0.000428	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.21e-05	0.000428	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.21e-05	0.000427	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.19e-05	0.000426	CbGpPWpGaD
Acepromazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	6.17e-05	0.0072	CrCbGaD
Acepromazine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	6.15e-05	0.00717	CrCbGaD
Acepromazine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.09e-05	0.000419	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.08e-05	0.000419	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.06e-05	0.000417	CbGpPWpGaD
Acepromazine—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	6.03e-05	0.000415	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.99e-05	0.000413	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.99e-05	0.000412	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.98e-05	0.000411	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.91e-05	0.000407	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.91e-05	0.000407	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.89e-05	0.000406	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.87e-05	0.000404	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.87e-05	0.000404	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.85e-05	0.000403	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.82e-05	0.000401	CbGpPWpGaD
Acepromazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	5.81e-05	0.00678	CrCbGaD
Acepromazine—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.79e-05	0.000399	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.77e-05	0.000397	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.77e-05	0.000397	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.76e-05	0.000396	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.73e-05	0.000395	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.7e-05	0.000392	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.7e-05	0.000392	CbGpPWpGaD
Acepromazine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	5.68e-05	0.00663	CrCbGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.64e-05	0.000388	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.64e-05	0.000388	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.59e-05	0.000385	CbGpPWpGaD
Acepromazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	5.55e-05	0.00648	CrCbGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.52e-05	0.00038	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.5e-05	0.000378	CbGpPWpGaD
Acepromazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	5.48e-05	0.00639	CrCbGaD
Acepromazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	5.48e-05	0.00639	CrCbGaD
Acepromazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	5.47e-05	0.00638	CrCbGaD
Acepromazine—Imipramine—DRD2—attention deficit hyperactivity disorder	5.45e-05	0.00636	CrCbGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.42e-05	0.000373	CbGpPWpGaD
Acepromazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	5.4e-05	0.00629	CrCbGaD
Acepromazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	5.34e-05	0.00623	CrCbGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.34e-05	0.000367	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.33e-05	0.000367	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.31e-05	0.000365	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.26e-05	0.000362	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.15e-05	0.000355	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.11e-05	0.000352	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.07e-05	0.000349	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.07e-05	0.000349	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.07e-05	0.000349	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.06e-05	0.000349	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.98e-05	0.000343	CbGpPWpGaD
Acepromazine—Desipramine—HTR2A—attention deficit hyperactivity disorder	4.97e-05	0.00579	CrCbGaD
Acepromazine—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.96e-05	0.000342	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.88e-05	0.000336	CbGpPWpGaD
Acepromazine—Promazine—HTR2A—attention deficit hyperactivity disorder	4.81e-05	0.00561	CrCbGaD
Acepromazine—ADRA1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.74e-05	0.000327	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.61e-05	0.000317	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.6e-05	0.000317	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.58e-05	0.000316	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.58e-05	0.000315	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.58e-05	0.000315	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.56e-05	0.000314	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.52e-05	0.000312	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.48e-05	0.000309	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.48e-05	0.000309	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.43e-05	0.000305	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.4e-05	0.000303	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.39e-05	0.000303	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.37e-05	0.000301	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.36e-05	0.000301	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.36e-05	0.0003	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.35e-05	0.0003	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.31e-05	0.000297	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.3e-05	0.000296	CbGpPWpGaD
Acepromazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	4.23e-05	0.00494	CrCbGaD
Acepromazine—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.21e-05	0.00029	CbGpPWpGaD
Acepromazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	4.21e-05	0.00491	CrCbGaD
Acepromazine—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.18e-05	0.000288	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.15e-05	0.000286	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.14e-05	0.000285	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.12e-05	0.000284	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.07e-05	0.00028	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.05e-05	0.000279	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.02e-05	0.000277	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.02e-05	0.000277	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.97e-05	0.000274	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.96e-05	0.000272	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.95e-05	0.000272	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.94e-05	0.000271	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.92e-05	0.00027	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.91e-05	0.000269	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.87e-05	0.000267	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.86e-05	0.000266	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.86e-05	0.000265	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.86e-05	0.000265	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.85e-05	0.000265	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.83e-05	0.000264	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.83e-05	0.000263	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.82e-05	0.000263	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.81e-05	0.000262	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	3.78e-05	0.00026	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.78e-05	0.00026	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.77e-05	0.000259	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.76e-05	0.000259	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.75e-05	0.000258	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.74e-05	0.000258	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.73e-05	0.000257	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.72e-05	0.000256	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.68e-05	0.000254	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.68e-05	0.000253	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.67e-05	0.000253	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.67e-05	0.000253	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.62e-05	0.00025	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.6e-05	0.000248	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.56e-05	0.000245	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.55e-05	0.000245	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.55e-05	0.000244	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000241	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.5e-05	0.000241	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000241	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.47e-05	0.000239	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.46e-05	0.000238	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.46e-05	0.000238	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.44e-05	0.000237	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.42e-05	0.000236	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.42e-05	0.000235	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.4e-05	0.000234	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000233	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000233	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.39e-05	0.000233	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.38e-05	0.000233	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.38e-05	0.000233	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.34e-05	0.00023	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.34e-05	0.00023	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.33e-05	0.000229	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.32e-05	0.000229	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.32e-05	0.000228	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000227	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000226	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.27e-05	0.000225	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.26e-05	0.000225	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.26e-05	0.000224	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.23e-05	0.000222	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.22e-05	0.000222	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.22e-05	0.000222	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.2e-05	0.00022	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.18e-05	0.000219	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.13e-05	0.000215	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.11e-05	0.000214	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.11e-05	0.000214	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.08e-05	0.000212	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.07e-05	0.000212	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.07e-05	0.000211	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.07e-05	0.000211	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.06e-05	0.000211	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.03e-05	0.000209	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.02e-05	0.000208	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	3.01e-05	0.000207	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.01e-05	0.000207	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.01e-05	0.000207	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3e-05	0.000207	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.99e-05	0.000206	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.96e-05	0.000204	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.96e-05	0.000204	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.92e-05	0.000201	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.92e-05	0.000201	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.89e-05	0.000199	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.78e-05	0.000192	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.76e-05	0.00019	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.72e-05	0.000188	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.72e-05	0.000187	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.67e-05	0.000184	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.62e-05	0.000181	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.55e-05	0.000175	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.48e-05	0.000171	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.45e-05	0.000168	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.41e-05	0.000166	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.4e-05	0.000166	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.37e-05	0.000163	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.36e-05	0.000163	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.35e-05	0.000162	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.34e-05	0.000161	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.31e-05	0.000159	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.29e-05	0.000158	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.26e-05	0.000156	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.26e-05	0.000155	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.22e-05	0.000153	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.21e-05	0.000152	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.18e-05	0.00015	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.17e-05	0.00015	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.15e-05	0.000148	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.1e-05	0.000145	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.1e-05	0.000145	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.07e-05	0.000142	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.07e-05	0.000142	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.05e-05	0.000141	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.04e-05	0.000141	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.02e-05	0.000139	CbGpPWpGaD
Acepromazine—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	2.02e-05	0.000139	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.02e-05	0.000139	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2e-05	0.000138	CbGpPWpGaD
Acepromazine—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	1.98e-05	0.000137	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.98e-05	0.000136	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.98e-05	0.000136	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.97e-05	0.000136	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.94e-05	0.000134	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.91e-05	0.000131	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.91e-05	0.000131	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.9e-05	0.000131	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.88e-05	0.000129	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.85e-05	0.000127	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.84e-05	0.000127	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.84e-05	0.000126	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	1.83e-05	0.000126	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000125	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.82e-05	0.000125	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.81e-05	0.000125	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000125	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.79e-05	0.000123	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	0.000123	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.78e-05	0.000123	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.76e-05	0.000121	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.75e-05	0.00012	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.73e-05	0.000119	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.64e-05	0.000113	CbGpPWpGaD
Acepromazine—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.61e-05	0.000111	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.61e-05	0.000111	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000107	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.53e-05	0.000106	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.33e-05	9.17e-05	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	1.29e-05	8.89e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.27e-05	8.74e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	1.22e-05	8.41e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	1.21e-05	8.35e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.18e-05	8.1e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.17e-05	8.05e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.76e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.21e-06	5.65e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	7.83e-06	5.39e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.06e-06	4.86e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.72e-06	4.63e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.2e-06	4.27e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.1e-06	4.2e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.97e-06	4.11e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	5.24e-06	3.61e-05	CbGpPWpGaD
